Susquehanna Fundamental Investments’s Charles River Laboratories CRL Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,583	Closed	-$543K	–	420
2023 Q2	$543K	Sell	2,583 -41,019	-94%	-$8.16M	0.02%	430
2023 Q1	$8.8M	Sell	43,602 -31,994	-42%	-$7.25M	0.21%	140
2022 Q4	$16.5M	Buy	75,596 +8,783	+13%	+$1.92M	0.28%	101
2022 Q3	$13.1M	Buy	+66,813	New	+$14.4M	0.22%	117
2022 Q1	–	Sell	-1,036	Closed	-$390K	–	1561
2021 Q4	$390K	Sell	1,036 -7,324	-88%	-$2.85M	0.01%	1015
2021 Q3	$3.45M	Sell	8,360 -7,550	-47%	-$3.14M	0.06%	413
2021 Q2	$5.88M	Sell	15,910 -10,393	-40%	-$3.47M	0.11%	260
2021 Q1	$7.62M	Buy	26,303 +1,036	+4%	+$288K	0.13%	211
2020 Q4	$6.31M	Buy	25,267 +2,237	+10%	+$533K	0.12%	244
2020 Q3	$5.21M	Buy	23,030 +12,637	+122%	+$2.62M	0.16%	175
2020 Q2	$1.81M	Buy	+10,393	New	+$1.66M	0.09%	308

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Susquehanna Fundamental Investments's CRL Position: Q3 2023 in Review

Susquehanna Fundamental Investments sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 2,583 shares — an estimated $543K sold.

Susquehanna Fundamental Investments first reported a position in CRL in Q2 2020 and held it in 11 quarters. The position peaked at $16.5M in Q4 2022. 622 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

Susquehanna Fundamental Investments reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 2,583 Charles River Laboratories shares in Q3 2023, an estimated $543K.
Susquehanna Fundamental Investments first reported a position in Charles River Laboratories in Q2 2020 and held it in 11 quarters.
Susquehanna Fundamental Investments's Charles River Laboratories position peaked at $16.5M in Q4 2022.
622 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2023, filed 14 Nov 2023.